Assessment by time-kill methodology of the synergistic effects of oritavancin in combination with other antimicrobial agents against Staphylococcus aureus.
about
Profile of oritavancin and its potential in the treatment of acute bacterial skin structure infectionsMethyl gallate from Galla rhois successfully controls clinical isolates of Salmonella infection in both in vitro and in vivo systemsComparison of the efficacy and safety of oritavancin front-loaded dosing regimens to daily dosing: an analysis of the SIMPLIFI trial.Antimicrobial Effects and Resistant Regulation of Magnolol and Honokiol on Methicillin-Resistant Staphylococcus aureusIntracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: study of antibiotic combinationsA comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin.Oritavancin for the treatment of acute bacterial skin and skin structure infections: an evidence-based review.Oritavancin: A Long-Half-Life Lipoglycopeptide.Oritavancin: a review in acute bacterial skin and skin structure infections.Bacteriostatic antimicrobial combination: antagonistic interaction between epsilon-viniferin and vancomycin against methicillin-resistant Staphylococcus aureus.Oritavancin: a long-acting antibacterial lipoglycopeptide.Comparative In Vitro Activities of Oritavancin, Dalbavancin, and Vancomycin against Methicillin-Resistant Staphylococcus aureus Isolates in a Nondividing State.Antistaphylococcal activity of oritavancin and its synergistic effect in combination with other antimicrobial agents.Oritavancin kills stationary-phase and biofilm Staphylococcus aureus cells in vitro.Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.Oritavancin (Orbactiv): A New-Generation Lipoglycopeptide for the Treatment Of Acute Bacterial Skin and Skin Structure Infections.In vitro antibacterial and time-kill evaluation of phosphanegold(I) dithiocarbamates, R3PAu[S2CN(iPr)CH2CH2OH] for R = Ph, Cy and Et, against a broad range of Gram-positive and Gram-negative bacteria
P2860
Q26799701-CA63860E-9B33-44B3-88B9-F8878E8A1CBDQ33928200-6551622C-A8FF-44A7-801B-3B4C1094AD48Q35065786-F4B333A0-3E5F-48AD-B3A3-DBB3029E37F3Q36017541-12E03BF9-5D82-46FC-8560-9BDDC879615CQ37144883-847AEDC3-E2F9-4070-9CD3-3E3DDB4E7C08Q37661510-DCE95BED-4660-48BC-BF16-7BCFAE68DFBBQ38364691-77325C55-59C8-4484-BBE5-B312DE14FDE2Q38434265-76DC96AC-49AB-45FC-A553-F676295D8D27Q38606618-CD0C12E8-0E1B-44B2-83D6-5F82A359F3F3Q38690166-D1FBB7C1-0B5C-4A41-B225-0AE58E938116Q38830176-E81A9EBC-E466-47DE-89AC-44363DAF52F1Q40719299-1BDF0A86-194B-4711-BE5E-EADC9B83A61DQ41810303-948C11CF-D978-499D-B3CD-F10743100B29Q43169904-501C3DC4-914F-4B12-8D03-49A735EB8B40Q43834023-8B2E666A-5A7E-45DC-8115-048AA77A5731Q52680606-001C7DA9-F874-4487-A151-6E833E5A1465Q59319251-9C932275-3046-4898-BAE5-452683280CC1
P2860
Assessment by time-kill methodology of the synergistic effects of oritavancin in combination with other antimicrobial agents against Staphylococcus aureus.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Assessment by time-kill method ...... against Staphylococcus aureus.
@en
Assessment by time-kill method ...... against Staphylococcus aureus.
@nl
type
label
Assessment by time-kill method ...... against Staphylococcus aureus.
@en
Assessment by time-kill method ...... against Staphylococcus aureus.
@nl
prefLabel
Assessment by time-kill method ...... against Staphylococcus aureus.
@en
Assessment by time-kill method ...... against Staphylococcus aureus.
@nl
P2093
P2860
P356
P1476
Assessment by time-kill method ...... against Staphylococcus aureus
@en
P2093
Adam Belley
Eve Neesham-Grenon
Francis F Arhin
Geoffrey A McKay
Thomas R Parr
P2860
P304
P356
10.1128/AAC.00361-08
P407
P50
P577
2008-07-21T00:00:00Z